InvestorsHub Logo
Followers 29
Posts 451
Boards Moderated 0
Alias Born 10/04/2008

Re: mojojojo post# 90967

Saturday, 09/08/2012 12:15:59 PM

Saturday, September 08, 2012 12:15:59 PM

Post# of 345830
Mojo-- Thanks for all the great graphs you give us. Any chance you could produce one that shows the KM curves for Avastin in NSCLC overlayed on yesterday's KM curve for Bavi at 3 mg/kg? Hopefully there is data out there showing Avastin survival numbers in Stage III an IV NSCLC patients.

After all, it's the total amount of space between the Bavi KM survival curve and the docetaxel control curve that drives the value of the BP partnership SK can command.

It would be a great visual if we could see not only the space between the Bavi line and the docetaxel line, but also the space between the Bavi OS line and the Avastin OS line. I strongly suspect that SK and his team are driving up the value of their BP deal by comparing Bavi's Kaplan Meir OS lines to Avastin's OS lines.

That one image would predict in a nutshell how much bigger the Bavi blockbuster effect in the marketplace will be as compared with the Avastin blockbuster effect.

Thanks in advance. FF
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News